German biometrics firm Jenetrics has announced the completion of a third investment round. In this latest round, the company was supported by VENTRADA Corporate Finance and Germany's most active and leading seed stage investor, High-Tech Gründerfonds (HTGF) has also confirmed its participation.”A strategy consequently focused on revenue and extension of the product portfolio has convinced us to once more invest into the powerful JENETRIC team”, said Karin Rabe, investment manager at bm|t, the investment company of the Free State of Thuringia.”Our investors' trust inspires and motivates us further. With the additional funds we mainly want to expand our production capacity and hit the ground running in the U.S. market”, said Roberto Wolfer, one of the founders and CEO of JENETRIC. To provide their customers in the U.S. with the best possible service, the company plans to establish a subsidiary there next year.”The US are pioneers and one of the most important markets for biometrics. For us the proximity to the critical multipliers of the industry is essential. This is the only way we can ensure the requirements for future biometric applications are captured in time and hence implemented in our products.”

Also in the news:

Default ThumbnailChaffey College selects BIO-key’s PortalGuard Default ThumbnailDelhi Metro plans biometric discount for students and elderly Default ThumbnailSwipe fingerprint feature planned for Nexus smartphones